BioMarin Pharmaceutical Inc News - BMRN | Aktien NASDAQ | ADVFN

Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

BioMarin Pharmaceutical Inc (BMRN)

66,03

0,61

(0,93%)

Geschlossen 30 November 10:00PM

Verzögert um 15 Minuten

66,2987

0,2687

(0,41%)

Nach Börsenschluss: 11:00PM

Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer

BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer PR Newswire SAN RAFAEL, Calif...

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

BioMarin Scheduled to Participate in March Investor Conferences

BioMarin Scheduled to Participate in March Investor Conferences PR Newswire SAN RAFAEL, Calif., March 1, 2024...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

4
5
6
Weiter

Foren

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

BioMarin Pharmaceutical

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen